ACR 2015 The Crossroads of Radiology

May 17, 2015 ‐ May 21, 2015


The ACR 2015 Virtual Conference is the perfect complement to your Annual Meeting registration.

This unique combination of live streaming video and over 100 hours of archived content will give you access to nearly every session for 12 months — giving you the ability to tailor your schedule in Washington, DC, so you don't miss a thing!

Total CE Credits: CE Credits have expired for these activities.

Member $349

Nonmember $449

MIT (resident/fellow) $249

The ACR 2015™ meeting offers a comprehensive learning experience focused on skill building in:

  • Advocacy
  • Economics and health policy
  • Clinical education
  • Clinical research
  • Informatics and innovations
  • Leadership
  • Medical physics
  • Radiation oncology
  • Quality and Safety

Earn CME, SA-CME and RLI Credits

CE Credits expired for these activities.

Accreditation Statement

The American College of Radiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The American College of Radiology designates this enduring material for a maximum of 140.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credits awarded for this enduring activity are designated “SA-CME” by the American Board of Radiology (ABR) and qualify toward fulfilling requirements for Maintenance of Certification (MOC) Part II: Lifelong Learning and Self-Assessment.

Released Date: 5/17/2015 - Expiration Date: 5/31/2016

The time needed to complete this enduring activity will be at a maximum of 140.75 hours.

Click Here for Subspecialty and Modality Legend

Acknowledgements

Education grant support for the ACR 2015 Virtual Meeting provided by:

  • GE HEALTHCARE
  • Philips Healthcare, a division of Philips Electronics North America Corporation

ACR Disclosure Policy / Conflict of Interest

In compliance with ACCME requirements and guidelines, the ACR has developed a policy for review and disclosure of potential conflicts of interest, and a method of resolution if a conflict does exist. The ACR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve this integrity and objectivity, all individuals participating as planners, presenters, moderators and evaluators in an ACR educational activity or an activity jointly sponsored by the ACR must appropriately disclose any financial relationship with a commercial organization that may have an interest in the content of the educational activity.

Faculty

Please see individual sessions for faculty disclosures.

Staff

ACR staff has indicated that they have no relevant financial relationships related to this educational activity.

Technical Specifications

Supported Browsers on Windows, Mac OS, or Linux

  • Google Chrome versions 33 and 34
  • Mozilla Firefox versions 28 and 29
  • Apple Safari versions 6 and 7
  • Microsoft Internet Explorer versions 10 and 11 (do not enable Compatibility View)

Standard: $449.00
ACR Member: $349.00
Member In Training: $249.00

Sessions

Preview Available

Lung Cancer Screening: From Science to Practice

May 17, 2015 10:00am ‐ May 17, 2015 12:00pm

Since lung cancer represents the number one cause of cancer-related mortality in the United States and throughout the developed world, the role of radiologists will be critical in the effective and responsible implementation of CT-based lung cancer screening. Such screening is the only method identified to date that allows for the preclinical detection of lung cancer such that appropriate intervention significantly reduces lung cancer mortality. The session will also include discussion of the National Lung Screening Trial and the role of ACRIN® in conceiving and conducting this pivotal trial.

Subspecialties: GEN, TH

Modalities: CT

Speaker(s): Disclosures
  • Consultant: Phillips Healthcare and MTR-Target
  • Consultant: Fovia, Inc., and GE Healthcare; Stock Options: HeartFlow
  • Consultant: Siemens Medical Solutions USA, Inc.

Preview Available

Recommendations for Incidental Findings on CT and MRI: How Useful, How Dangerous, and How to Make Them Work

May 17, 2015 10:00am ‐ May 17, 2015 11:30am

The purpose of this session is to discuss why and how the ACR incidental findings white papers came about and to expose some of the controversies surrounding these recent efforts. Although the methods for developing these recommendations and their scope will be described, the majority of the session will address their strengths and weaknesses and issues regarding how they should be maintained, improved, and disseminated more broadly. The session will also include a discussion on the relationship between quality outcomes and consistency relative to current widespread practice variability. 

Subspecialties: GI, GU, OB,  WI
Modalities: CT, MRI

Speaker(s): Disclosures
  • Consultant: Nuance Communications; Ownership/Partnership: Nuance Communications
  • Consultant: Siemens Healthcare; Salary: Siemens Healthcare

Preview Available

Hospital Contracting: Tips and Pitfalls

May 17, 2015 10:00am ‐ May 17, 2015 12:00pm

This session will discuss hospital contract negotiations from the perspective of both the radiologist and the attorney. It will discuss basic negotiation principles that can be applied to hospital contracting, and it will give examples of contract clauses that should be avoided or modified.  Emphasis will be placed on achieving a positive result that benefits the practice, the hospital, and the patients. Time will be available for an interactive Q & A session. Attendees are encouraged to bring to the session their practice specific concerns and issues.

Subspecialties: NIS
Modalities: NI

Speaker(s): Disclosures
  • Officer, Director: Imaging Consultants, Inc
  • Officer, Director: Boston Imaging Core Labs; Ownership/Partnership: Boston Imaging Core Labs

Preview Available

ACR Ed. Center: Abdomen and Pelvic MR

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

This session is focused on abdominal and pelvic MR imaging interpretation for the most common current indications for abdominal and pelvic MR imaging of the liver, pancreas, pelvis, and kidneys.  

Subspecialties: GU, RE
Modalities: MRI

Speaker(s): Disclosures
  • Research Grants: Siemens Medical Solutions USA, Inc.

Preview Available

Lung Cancer Screening: CT Interpretation and Management

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

The purpose of this session is to discuss how to manage the positive lung cancer screening CT scan and to review case-based presentations that teach the interpretation and workup of lung cancer screening scans.  The session also discusses the ACR-initiated Lung-RADS standard for the structured reporting of lung cancer screening CT scans. 

Subspecialties: GEN, TH
Modalities: CT

Speaker(s): Disclosures
  • Consultant: Siemens Medical Solutions USA, Inc., and Vital Images, Inc
  • Research Grants(Spouse/Partner): Toshiba Medical Systems

Preview Available

Metrics and Pay-for-Performance

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

This session will introduce the concept of metrics specific to medical imaging and discuss the role and activities of the ACR Metrics Committee. The process of measure development for use in pay-for-performance programs such as the CMS Physician Quality Reporting System (PQRS) and private insurance programs, including the roles of the AMA Physician Consortium for Performance Improvement (PCPI) and the National Quality Forum will be discussed as well as the history of the PQRS program and the relative performance of radiologists compared to other physicians. Also highlighted will be the status of PQRS in 2015, which includes requirements to comply with PQRS and measures available for claims-based reporting and registry reporting. The session will conclude with a look to the future of performance-based compensation, which may change substantially with replacement of the Sustainable Growth Rate process. 

Subspecialties: GEN
Modalities: NI
 

Speaker(s): Disclosures
  • Consultant: various clients; Officer, Director: RAMG Inc.; MCR MRAP; Ownership/Partnership: RAMG Inc.; MCR MRAP; Salary: Sutter Medical Group
  • Research Grants: Toshiba Medical Systems

Preview Available

New Payment Models Meet Big Data

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

As healthcare delivery models evolve into ones that reward value over volume, the mechanisms by which physicians and facilities will be compensated will change. To date, there is little consensus on how radiologists and radiology departments will be addressed under new payment models. This program intends to demonstrate the power of historical analytic data in forming the baseline for innovative local and national payment models that will align stakeholder interests. Increasingly, practice leaders will be required to establish contracts based on risk and value. Given the seeming lack of information regarding new payment models and how they are actually implemented, it is easy for radiologists to feel hopeless or powerless against the oncoming tide of change. This session will show how, using data and analytics, radiology and radiologists can regain control of their financial stake in the patient encounter. Although big data and analytics may sound like somethings that cannot affect your day-to-day practice as a radiologist, it turns out that having powerful tools work in the background can allow for better, more consistent reports, better communication of critical results and follow-up, and a more proactive, rather than reactive, radiology practice.

Subspecialties: NIS
Modalities: NI

Speaker(s): Disclosures
  • Research Grants: Harvey Neiman Health Policy Institute Grant

Preview Available

Reshaping Radiology Through Mobile: Apps, Technologies, and FDA Regulations

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

Mobile computing devices and apps, as in every other industry, will provide opportunities for innovation in health care. This session will include a discussion of mobile trends, apps, and pending FDA regulations that will have enormous impact on the practice of radiology. 

Subspecialties: NIS
Modalities: NI

Speaker(s): Disclosures
  • Consultant and Stockholder: Image Safely, Inc and Angular Health, Inc

Preview Available

Setting the Record Straight on America's Healthcare

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

This session exposes the facts about the state of America's healthcare, facts that are critical for healthcare providers, especially those in technology-based fields like radiology, to understand. First, it revisits and analyzes the documents and statistics often cited as evidence that medical care in the United States is substandard and a poor value relative to that of other countries. Second, it provides evidence to answer the paramount question when considering quality of healthcare, 'Where do you want to be if you are sick?' The facts- as documented in scientific and medical journals- about access to medical care and medical care quality in the most important diseases in the United States are compared with other countries having nationalized health systems often held up as models for US health system reforms. Third, the important components of Obamacare and their impact will be reviewed. Last, specific alternative reforms to reduce the cost and fix the inadequacies of this country's health care without jeopardizing its distinction are outlined.  

Subspecialties: NIS
Modalities: NI

Speaker(s): Disclosures
  • Officer, Director: Boston Imaging Core Labs; Ownership/Partnership: Boston Imaging Core Labs
  • Honoraria: GE Healthcare

Preview Available

Steven Leibel Memorial Lecture: Therapeutic Gain From Technologic Advances in Radiation Oncology

May 17, 2015 1:30pm ‐ May 17, 2015 3:00pm

This session will highlight how technologic advances have improved therapeutic gain in radiation oncology and how these advances may be combined with biologic advances to further move the field forward and improve the outcomes and quality of life of patients undergoing radiation therapy. The session will address how new technologies have improved outcomes and reduced toxicities resulting in a therapeutic gain.   

Subspecialties: MI, RO
Modalities: CT

Speaker(s): Disclosures
  • Honoraria: Bristol-Myers Squibb, Eli Lily and Company,  Abbvie; Stock Options: Merck Oncology